Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2041-1723
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma ; volume:13 ; number:1 ; day:29 ; month:10 ; year:2022 ; pages:1-17 ; date:12.2022
Nature Communications ; 13, Heft 1 (29.10.2022), 1-17, 12.2022

Creator
Tomaszewski, William H.
Waibl-Polania, Jessica
Chakraborty, Molly
Perera, Jonathan
Ratiu, Jeremy
Miggelbrink, Alexandra
McDonnell, Donald P.
Khasraw, Mustafa
Ashley, David M.
Fecci, Peter E.
Racioppi, Luigi
Sanchez-Perez, Luis
Gunn, Michael D.
Sampson, John H.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41467-022-34175-y
URN
urn:nbn:de:101:1-2023011409255147681195
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Tomaszewski, William H.
  • Waibl-Polania, Jessica
  • Chakraborty, Molly
  • Perera, Jonathan
  • Ratiu, Jeremy
  • Miggelbrink, Alexandra
  • McDonnell, Donald P.
  • Khasraw, Mustafa
  • Ashley, David M.
  • Fecci, Peter E.
  • Racioppi, Luigi
  • Sanchez-Perez, Luis
  • Gunn, Michael D.
  • Sampson, John H.
  • SpringerLink (Online service)

Other Objects (12)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

STING cg16983159 methylation: a key factor for glioblastoma immunosuppression

STING cg16983159 methylation: a key factor for glioblastoma immunosuppression

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

Immune checkpoint blockade in ovarian cancer

Immune checkpoint blockade in ovarian cancer

Smoldering myocarditis following immune checkpoint blockade

Smoldering myocarditis following immune checkpoint blockade

Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer

Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer

Immunosuppression

Immunosuppression

Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment

Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment

Activation of phagocytosis by immune checkpoint blockade

Activation of phagocytosis by immune checkpoint blockade

Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer

Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression

Related objects